(MED 301) NEOPLASIA AND HEMATOPOIETIC SYSTEMS DISEASES COMMITTEE (4 WEEK) CODE DISCIPLINE THEORETIC AL

Similar documents
(MED 307) GASTROINTESTINAL SYSTEM DISEASES COMMITTEE (4 WEEK)

OKAN UNIVERSITY FACULTY OF MEDICINE ACADEMIC YEAR PHASE III COMMITTEE II

(MED 302) UROGENITAL and ENDOCRINE SYSTEM DISEASES COMMITTEE (6 WEEK)

CODE DISCIPLINE THEORETICAL PRACTICAL TOTAL 1-ANESTHESIOLOGY AND REANIMATION

CODE DISCIPLINE THEORETICAL PRACTICAL TOTAL 1-CLINICAL BIOCHEMISTRY

Lahey Clinic Internal Medicine Residency Program: Curriculum for Hematology

YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY

LIST OF PARTICIPANTS IN THE SUBJECT COMMITTEE

SUMMARY OF THE COMMITTEE-II

GASTROINTESTINAL SYSTEM AND METABOLISM COMMITTEE (MED203) 8 WEEK PROGRAMME ( )

ENDOCRINE & UROGENITAL SYSTEM COMMITTEE (MED202) 5 WEEK PROGRAMME ( )

ACGME Program Requirements for Graduate Medical Education in Pediatric Hematology-Oncology

OKAN UNIVERSITY FACULTY OF MEDICINE ACADEMIC YEAR PHASE III COMMITTEE VII

Diseases Of The Blood

Index. Note: Page numbers of article titles are in boldface type.

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization

Done By : WESSEN ADNAN BUTHAINAH AL-MASAEED

Course Outline: Blood and Immunology. DRAFT 14 May 2013

2. Occupancy rate of beds in the hospital: Occupancy rate of at least 60%

STUDY GUIDE. At the end of the module, the students should be able to: Outcomes

CARDIOVASCULAR AND RESPIRATORY SYSTEM COMMITTEE (MED201) 7 WEEK PROGRAMME ( )

HEMATOLOGY MODULE STUDY GUIDE Course Title Hematology Module B Course Coordinator: Dr. Irfan Ashraf

Curriculum: Goals and Objectives Department of Medicine Harbor-UCLA Medical Center

July 3, The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244

Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure

CHAPTER:4 LEUKEMIA. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY 8/12/2009

PEDIATRIC HEMATOLOGY/ONCOLOGY ROTATION

QUESTIONS OF HEMATOLOGY AND THEIR ANSWERS

VA Hematology/Oncology Elective

CASPER COLLEGE MLTK 1500 HI Clinical Hematology and Hemostasis. Lecture Hours: 2 Lab Hours: 4 Credit Hours: 3

Care of the Patient with a Blood or Lymphatic Disorder. ph Volume pints. Red blood cells (RBC) White blood cells (WBC)

BIOLOGY 2290 Pathophysiology I (Health Sciences III ) Sept 2010 Instructor : Dr. Paul S. Sunga, Rm A359a, , Introduction

Lymphatic System Disorders

Myelodyplastic Syndromes Paul J. Shami, M.D.

(anemia) ก hemoglobin concentration, hematocrit deviation 1 1 ก hemoglobin, hematocrit mean corpuscular volume (MCV) 2

General Pathology Theory Syllabus for II B.D.S.

Hematology/Oncology/BMT

Hematological diseases

The Evaluation and Classification of Anemia

Pathology of Hematopoietic and Lymphoid tissue

CELL-MEDIATED IMMUNITY

Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology

University of Michigan Health System Internal Medicine Residency. Hematology/Oncology Curriculum: University Hospital Hematology Consultation Service

Saint James School of Medicine

155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary

SYLLABUS ON HEMATOLOGY FOR THE 4-YEAR STUDENTS, MEDICINE-2. Total hours number 70 hours, including course 20 hours, seminars 50 hours.

The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam:

Infections and nonmicrobial inflammatory stimuli can cause leukocytosis (as seen in Lab 1) as well as lymph node enlargement (lymphadenopathy).

UNMH Hematology/Oncology Clinical Privileges

1. Adequate diet and iron intake to prevent iron deficiency 2. Signs and symptoms of malignant disease

Al-Balqa Applied University Faculty of Medicine

Regions Hospital Delineation of Privileges Internal Medicine Hematology / Oncology

Table 8.1. Epidemiology of Leukemia in the United States (2010) Annual Deaths. Mean Age. Percentage of All Leukemias (%) (Number of New Cases)

Pediatric Hematology-Oncology

Hematology Page 1 of 8

Pathology of Hematopoietic and Lymphoid tissue

Lymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC

Classification of Hematologic Malignancies. Patricia Aoun MD MPH

Electrocardiography Gönenç Kocabay Electrocardiography Gönenç Kocabay Electrocardiography Gönenç Kocabay

REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2015 and after

CHRONIC LYMPHOCYTIC LEUKEMIA

Symptoms and Signs in Hematology/ 2013

MYELODYSPLASTIC AND MYELOPROLIFERATIVE

Microcytic Hypochromic Anemia An Approach to Diagnosis

DEPARTMENT OF CLINICAL HEMATOLOGY

Latest Press Release. Celexa italiano

Index. Note: Page numbers of article titles are in boldface type.

WBCs Disorders 1. Dr. Nabila Hamdi MD, PhD

Melanoma Case Scenario 1

Chapter 46. Care of the Patient with a Blood or Lymphatic Disorder

Culture Advantage. Anatomy and Medical Terminology for Interpreters ONCOLOGY TERMINOLOGY

Subspecialty Inpatient Rotation: Pediatric Oncology at Memorial Sloan Kettering Cancer Center Senior Resident

Clinical Privileges Profile Hematology/Oncology. Kettering Medical Center System

Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89

SICKLE CELL DISEASE. Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH. Assistant Professor FACULTY OF MEDICINE -JAZAN

Disorders of Blood Cells & Blood Coagulation

STUDY GUIDE. At the end of the module, students should be able to:

Clinical & Laboratory Assessment

BIT 120. Copy of Cancer/HIV Lecture

Index. Note: Page numbers of article titles are in boldface type.

Melanoma Case Scenario 1

Squamous neck cancer survival rate

PCCN Review Hematology

Hematology Unit Lab 2 Review Material

REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2017 and after

The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011)

Normal Development. Normal Development 10/16/2012. Hematopoietic and Lymph Node Pathology. Red Blood Cell Maturation & Anemias

PATHOLOGY & PATHOPHYSIOLOGY

Drop of Blood Unravels Mysteries. Prof. Salma Afrose Department of Hematology Dhaka Medical College

Assessment and management of patients with hematologic disorder أ.م.د.وداد كامل محمد فرع تمريض البالغين

Recommended Timing for Transplant Consultation

Reactive and Neoplastic Lymphocytosis

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA. April 16, 2008

Pathology of the Lymphoid System

Hematologic changes in systemic diseases. Chittima Sirijerachai

Part II The Cell Cell Division, Chapter 2 Outline of class notes

Peripheral Blood Smear: Diagnostic Clues and Algorithms

Overview of Cutaneous Lymphomas: Diagnosis and Staging. Lauren C. Pinter-Brown MD, FACP Health Sciences Professor of Medicine and Dermatology

Overview of Aplastic Anemia. Overview of Aplastic Anemia. Epidemiology of aplastic anemia. Normal hematopoiesis 10/6/2017

California Cancer Registry Production Automation and Quality Control Unit Data Alert - Registrar

Transcription:

OKAN UNIVERSITY FACULTY OF MEDICINE 2017 2018 ACADEMIC YEAR PHASE III COMMITTEE I (MED 301) NEOPLASIA AND HEMATOPOIETIC SYSTEMS DISEASES COMMITTEE 11.09.2017-06.10.2017 (4 WEEK) CODE DISCIPLINE THEORETIC AL PRACTIC AL MED301 1-CLINICAL BIOCHEMISTRY 6 6 TOTAL MED301 2-MEDICAL PHARMACOLOGY 10 10 MED301 3-MEDICAL ONCOLOGY 17 17 MED301 4-PATHOLOGY 10 2 12 MED301 5- PEDIATRICS 19 19 MED301 6-GENETICS 6 6 MED301 7- RADIATION ONCOLOGY 5 5 MED301 8- CHEST SURGERY 2 2 MED301 9-NUCLEAR MEDICINE 4 4 MED301 10- EAR, NOSE AND THROAT 2 2 MEDICAL LECTURES TOTAL HOURS 81 2 83 OTHER COURSE 10-HAPPY LIFE 6 6 TOTAL 87 2 89 DEAN COORDINATOR IN CHIEF COORDINATOR OF PHASE III ASSISTANT COORDINATOR : Prof. Dr. Semih BASKAN : Prof. Dr. A. Demet KAYA : Prof. Dr. Okan BÖLÜKBAŞI : Assist. Prof. Dr. Nermin BÖLÜKBAŞI

LIST OF PARTICIPANTS IN THE SUBJECT COMMITTEE DEPARTMENTS LECTURERS 1- CLINICAL BIOCHEMISTRY Prof. Murat BOLAYIRLI 2- MEDICAL PHARMACOLOGY BÖLÜKBAŞI 3- MEDICAL ONCOLOGY Assist. Prof. Sinemis ÇELİK 4-PATHOLOGY 5- PEDIATRICS Dr. Özben Yalçın Prof. Emin ÜNÜVAR Assist. Prof. Şenol Bozdağ 6- GENETICS Assist. Prof. Hakan BERKIL 7- RADIATION ONCOLOGY Prof. Metin GUDEN Assist. Prof. Tayfun Hancılar 8- CHEST SURGERY Prof. Muzaffer METIN 9- NUCLEAR MEDICINE Prof. Kerim SÖNMEZOĞLU 10- EAR, NOSE AND THROAT Prof. İsmail Koçak

MEDICINE PHASE III 11.09.2017 12.09.2017 13.09.2017 MED301-WEEK1 09. 00-09. 50 10. 00-10. 50 11. 00-11. 50 Opening ceremony 12. 00-12. 50 13 30-14. 20 14. 30-15. 20 15. 30-16. 20 16. 30-17. 20 09. 00-09. 50 Pathology; Neoplasia: Nomenclature Dr. Özben Yalçın 10. 00-10. 50 Pathology; Benign and malignant tumors Dr. Özben Yalçın 11. 00-11. 50 Pathology; Karsinogenesis, Patology of Karsinogenesis Dr. Özben Yalçın 12. 00-12. 50 Pathology; Patology of Metastasis Dr. Özben Yalçın 09. 00-09. 50 Pediatrics; Child Patient Approach Prof. Emin Unuvar 10. 00-10. 50 Pediatrics; Anamnesis in pediatric patients Prof. Emin Unuvar 11. 00-11. 50 Pediatrics; Evaluation of the skin and subcutaneous tissue Prof. Emin Unuvar 13 30-14. 20 Medical Oncology; The pathophysiology of cancer Assist. Prof. Sinemis ÇELİK 14. 30-15. 20 Medical Oncology; Bone marrow failure tables Assist. Prof. Sinemis ÇELİK 15. 30-16. 20 Medical Oncology; Plasma cell disease Assist. Prof. Sinemis ÇELİK 09. 00-09. 50 Pediatrics; Neonatal examination Assist. Prof. Şenol Bozdağ 10. 00-10. 50 Pediatrics; Newborn screening tests Assist. Prof. Şenol Bozdağ Perşembe / Thursday 14.09.2017 13 30-14. 20 Medical Oncology; Adult Patient Approach Assist. Prof. Sinemis ÇELİK 14. 30-15. 20 Medical Oncology;Anamnesis in Adult patients Assist. Prof. Sinemis ÇELİK Cuma / Friday 15.09.2017 11. 00-11. 50 Pediatrics; Head, face and eye examination Prof. Emin Unuvar

12. 00-12. 50 Pediatrics; Ear, nose and throat examination Prof. Emin Unuvar 18.09.2017 19.09.2017 20.09.2017 Perşembe / Thursday 21.09.2017 13 30-14. 20 Medical Oncology; Acute Leukemia Assist. Prof. Sinemis ÇELİK 14. 30-15. 20 Medical Oncology; Lymphocytosis and CLL Assist. Prof. Sinemis ÇELİK 15. 30-16. 20 Happy Life 16. 30-17. 20 Happy Life MED301-WEEK2 09. 00-09. 50 Genetics; Overview of chromosomal disorders Assist. Prof. Hakan Berkil 10. 00-10. 50 Genetics; Overview of single gene disorders Assist. Prof. Hakan Berkil 11. 00-11. 50 Pediatrics; Risk Newborn and Newborn care Assist. Prof. Şenol Bozdağ 12. 00-12. 50 Pediatrics; Newborn Jaundice Assist. Prof. Şenol Bozdağ 13 30-14. 20 Medical Oncology; Chronic myeloproliferative neoplasms Assist. Prof. Sinemis ÇELİK 14. 30-15. 20 Medical Oncology; Chronic myeloproliferative neoplasms Assist. Prof. Sinemis ÇELİK 09. 00-09. 50 Genetics; The most common genetic diseases Assist. Prof. Hakan Berkil 10. 00-10. 50 Genetics; The genetic basis of cancer Assist. Prof. Hakan Berkil 11. 00-11. 50 Medical pharmacology: General Principles of Cancer Chemotherapy 12. 00-12. 50 Medical pharmacology: General Principles of Cancer Chemotherapy 13 30-14. 20 Radiation Oncology; Clinical Radiation oncology physics Prof. Metin Güden 14. 30-15. 20 Radiation Oncology; Head and neck cancers Prof. Metin Güden 09. 00-09. 50 Radiation Oncology; Leukemias and lymphomas Prof. Metin Güden 10. 00-10. 50 Radiation Oncology; Childhood cancers Prof. Metin Güden 11. 00-11. 50 Pediatrics; Clinical assessment of growt and development Prof. Emin Unuvar 12. 00-12. 50 Pediatrics; Clinical assessment of growt and development Prof. Emin Unuvar 13 30-14. 20 Nuclear Medicine; Basic principles of scintigraphic imaging Prof. Kerim Sonmezoglu 14. 30-15. 20 Nuclear Medicine; Basic principles of radionuclide treatments Prof. Kerim Sonmezoglu 15. 30-16. 20 Medical Oncology;Lymphomas Assist. Prof. Sinemis ÇELİK 16. 30-17. 20 Medical Oncology; Lymphomas Assist. Prof. Sinemis ÇELİK 09. 00-09. 50 Medical pharmacology: Anticancer drugs 10. 00-10. 50 Medical pharmacology: Anticancer drugs 11. 00-11. 50 Genetics; Oncogenes and tumor suppressor genes Assist. Prof. Hakan Berkil 12. 00 50 Genetics; Cancer gene pathways, cancer genom and genetic -12. instability,genetic alterations in common cancer 13 30-14. 20 Clinical Biochemistry; Circulating tumor markers : Basic concepts and clinical applications 14. 30 20 Clinical Biochemistry; Circulating tumor markers : Basic concepts -15. and clinical applications Assist. Prof. Hakan Berkil Prof. Murat Bolayırlı Prof. Murat Bolayırlı

Cuma / Friday 22.09.2017 09. 00-09. 50 Radiation Oncology; Lung Carcinoma 10. 00-10. 50 11. 00-11. 50 Assist. Prof. Tayfun Hancılar 13 30-14. 20 Pediatrics; Evaluation of superficial lymph node Prof. Emin Unuvar 14. 30-15. 20 Pediatrics; Hematologic System Inspection, Peripheral Smear Evaluation 15. 30-16. 20 Happy life 16. 30-17. 20 Happy life Prof. Emin Unuvar 25.09.2017 26.09.2017 27.09.2017 Perşembe / Thursday 28.09.2017 MED301-WEEK3 09. 00-09. 50 Pathology; Introductıon to Lymph node Pathology Dr. Özben Yalçın 10. 00-10. 50 Pathology; Lymphadenitis Dr. Özben Yalçın 11. 00-11. 50 Pathology; Neoplastic Proliferations of White Cells: Hodgkin Disease 12. 00-12. 50 Pathology; Neoplastic Proliferations of White Cells: Non-Hodgkin Disease Dr. Özben Yalçın Dr. Özben Yalçın 13 30-14. 20 Pediatrics; Hematologic and oncologic patient approach Prof. Emin Unuvar 14. 30-15. 20 Pediatrics; Anemia approach Prof. Emin Unuvar 15. 30-16. 20 Medical Oncology; Normocytic anemia Assist. Prof. Sinemis ÇELİK 16. 30-17. 20 Medical Oncology; Microcytic Anemia Assist. Prof. Sinemis ÇELİK 09. 00-09. 50 Pathology; Bone marrow pathology Dr. Özben Yalçın 10. 00-10. 50 Pathology; Spleen and Thymus Dr. Özben Yalçın 11. 00-11. 50 Pathology lab; Dr. Özben Yalçın 12. 00-12. 50 Pathology lab; Dr. Özben Yalçın 13 30-14. 20 Medical pharmacology: Anticancer drugs 14. 30-15. 20 Medical pharmacology: Anticancer drugs 09. 00-09. 50 Ear, Nose and Throat; Head and Neck Tumours Prof. İsmail Koçak 10. 00-10. 50 Ear, Nose and Throat; Head and Neck Tumours Prof. İsmail Koçak 11. 00-11. 50 Pediatrics; Hepato- splenomegaly Prof. Emin Unuvar 12. 00-12. 50 Pediatrics; Jaundice Prof. Emin Unuvar 13 30-14. 20 Nuclear Medicine; Nuclear oncology-conventional scintigraphy Prof. Kerim Sonmezoglu 14. 30-15. 20 Nuclear Medicine; Nuclear oncology-positron Emission Tomography Prof. Kerim Sonmezoglu 15. 30-16. 20 Medical Oncology; Macrocytic anemia Assist. Prof. Sinemis ÇELİK 16. 30-17. 20 Medical Oncology; Hemostasis disorders Assist. Prof. Sinemis ÇELİK 09. 00-09. 50 Clinical Biochemistry; Hemoglobinopathies and thalassemias Prof. Murat Bolayırlı 10. 00-10. 50 Clinical Biochemistry; Hemoglobinopathies and thalassemias Prof. Murat Bolayırlı 11. 00-11. 50 Clinical Biochemistry; Biochemical aspects of anemia Prof. Murat Bolayırlı

Cuma / Friday 29.09.2017 12. 00-12. 50 Clinical Biochemistry; Biochemical aspects of anemia Prof. Murat Bolayırlı 13 30-14. 20 Medical Pharmacology: Immunosuppressants 14. 30-15. 20 Medical Pharmacology: Immunosuppressants 15. 30-16. 20 Medical Oncology; Thrombocytopenia and platelet function disorders. Assist. Prof. Sinemis ÇELİK 16. 30-17. 20 Medical Oncology; Blood products and transfusion Assist. Prof. Sinemis ÇELİK 09. 00-09. 50 Chest Surgery; Introduction to lung cancers Prof. Muzaffer Metin 10. 00-10. 50 Chest Surgery; Introduction to lung cancers Prof. Muzaffer Metin 11. 00-11. 50 Pediatrics; Iron deficiency anemia Prof. Emin Unuvar 12. 00-12. 50 Pediatrics; Common coagulation disorders in pediatrics Prof. Emin Unuvar 13 30-14. 20 Medical Pharmacology: Drugs for Anemia 14. 30-15. 20 Medical Pharmacology: Drugs for Anemia 15. 30-16. 20 Happy life 16. 30-17. 20 Happy life 02.10.2017 03.10.2017 04.10.2017 MED301-WEEK4

Perşembe / Thursday 05.10.2017 Cuma / Friday 06.10.2017 09. 00-09. 50 10. 00-10. 50 Theoretical Exam- Practical Exam 11. 00-11. 50 12. 00-12. 50 13 30-14. 20 14. 30-15. 20 15. 30-16. 20 16. 30-17. 20